Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary Cholangitis. [PDF]
Schattenberg JM +8 more
europepmc +1 more source
Current perspectives on lipid management in diabetic kidney disease: Can fibrates offer advantages over statins for renal outcomes? [PDF]
Chitsazi MR +9 more
europepmc +1 more source
Deletion of <i>Bmal1</i>, a Component of the Molecular Clock, Exacerbates Kidney Damage After Ischemia-Reperfusion by Decreasing <i>Pparα</i> Expression. [PDF]
Kitaura S, Wada T, Asano Y, Shimba S.
europepmc +1 more source
Development and evaluation of an effective solubility prediction model for pharmaceuticals in organic solvents using machine learning based on eXtreme Gradient Boosting. [PDF]
Valavi M +3 more
europepmc +1 more source
Fenofibrate therapy and risk of heart failure outcomes in patients with Type 2 diabetes: a propensity-matched cohort study. [PDF]
Kim JY, Kim NH, Lee J, Kim DH, Kim SG.
europepmc +1 more source
Long-acting fenofibrate-loaded microparticles for treating retinal disorders. [PDF]
Poudel S +11 more
europepmc +1 more source
Fenofibrate differentially activates PPARα-mediated lipid metabolism in rat kidney and liver. [PDF]
Pannala VR +8 more
europepmc +1 more source
Tirzepatide-associated interstitial kidney injury. [PDF]
Eldib M +5 more
europepmc +1 more source
PPARα modulation of macrophage polarization and inflammatory signaling in mimic periodontitis. [PDF]
Arthur HU, Chen YY.
europepmc +1 more source
PPARα: Linking Cardiac Metabolism to Therapeutic Opportunities in Cardiovascular Diseases. [PDF]
Roes M, Libert C, Vandewalle J.
europepmc +1 more source

